The threat of antimicrobial resistance has increased substantially since the start of the COVID-19 pandemic, and while a host of diagnostic tools are available, these life-threatening infections still pose a threat due to limitations of tests, especially those that are rapid.
Due to the urgency in encouraging the public to get vaccinated against the SARS-CoV-2 virus, the message concerning the importance of widespread testing has been neglected, creating a lack of data needed for study by scientists.
While acetylcholinesterase inhibitors, corticosteroids and thymectomy are generally considered first-line therapies for MG, many patients additionally require proven immunosuppressive therapies (ISTs) such as azathioprine, cyclosporine/tacrolimus or mycophenolate mofetil, or immunomodulatory therapies, including intravenous immune globulin (IVIG) or plasma exchange (PLEX).
With the number of older adults in the U.S. predicted to double in the coming decades, how these individuals perceive the effects of aging may directly relate to how long and healthfully they live.
The race is on to develop new medications that effectively block pain receptors to help reduce the suffering of migraineurs.
The pandemic has left the healthcare system with staffing and revenue shortages, as well as supply chain management challenges, that are expected to extend into the foreseeable future.
Experts set the record straight about common misunderstandings regarding IVIG and SCIG products, their administration and possible reactions.
A new study demonstrates how severe acute respiratory syndrome coronavirus disease 2 (SARS-CoV-2) infection could be associated with an autoimmune response and development of autoantibodies.
Transition of clinic-based to home-based intravenous immune globulin (IVIG)/subcutaneous IG (SCIG) infusion can be successfully done to decrease potential exposure during a pandemic in a high-risk immunosuppressed population.
Two recent studies effectively determined the antibody responses of pregnant women infected with SARS-CoV-2 and the effect of the fetal sex on those responses, as well as the direct clinical implications for COVID-19 infection and future maternal-fetal vaccination strategies.
Understanding the factors contributing to the current shortage of immune globulin could help to address a crisis that threatens dire consequences for patients.
Understanding terms used in rule sets pertaining to payment for inpatients, which go into effect during the fiscal year effective Oct. 1, as well as outpatient and physician fee services, which go into effect during the calendar year effective Jan. 1.
